Research and analysis

Laboratory reports of hepatitis C infections in England and Wales: April to June 2024

Published 27 February 2025

Applies to England and Wales

Between April and June, a total of 4,646 laboratory reports of hepatitis C were reported to the UK Health Security Agency (UKHSA) (previously PHE).

There was a 52% increase in the number of reports compared to the first quarter of 2021 (n=2,432). This increase is due to the addition of previously missing backdated confirmed hepatitis C laboratory reports originating from either the private laboratory Abbott (formerly known as Alere), or a laboratory from the North West region.   

Since 2017, one laboratory in north-west England has undertaken HCV dried blood spot testing alongside hepatitis C routine laboratory testing. This single laboratory has taken on testing for a large part of the country; however, some samples where geographical information is lacking may have been incorrectly assigned to this specific laboratory rather than the laboratory from which the sample originated.

Age and sex were well reported (96% complete). Where sex was known, males accounted for 70% (3,146 out of 4,476) of reports, which is consistent with previous quarters and years. Adults aged 35 to 54 years accounted for 31% of the total number of hepatitis C reports.

Table 1. Laboratory reports of hepatitis C in England and Wales, April to June 2024*

Age group Males Females Unknown Total
1 to 4 years 1      0      0      1
5 to 9 years 1      1      0      2
10 to 14 years 2      3      1      6
15 to 24 years 47      32      12      91
25 to 34 years 248      132      48      428
35 to 44 years 506      218      165      889
45 to 54 years 464      185      142      791
55 to 64 years 316      208      72      596
≥65 years 240      203      15      458
Unknown 17      11      24      52
Total 1,842   993    479    3,314

*Provisional data.

Notes: Individuals aged under 1 year are excluded, since positive tests in this age group may reflect the presence of passively-acquired maternal antibody rather than true infection. Laboratory reports are not reliable for differentiating acute and chronic hepatitis C infections. Laboratory reports include individuals with a positive test for hepatitis C antibody, antigen and/or detection of hepatitis C RNA. A small proportion of these specimens are diagnosed following DBS testing, however not all DBS testing is reported by laboratories.

In Table 2, laboratory reports are presented broken down by Operational Delivery Network (ODN). ODNs were launched in July 2013 following the publication of the NHS England strategy to sustain and develop clinical networks.

ODNs are the networks through which hepatitis C treatment is being delivered across England. Between April and June 2024, 3,021 out of 3,849 individuals in England have been allocated to an ODN.

Table 2. Laboratory reports of hepatitis C by Operational Delivery Network, April to June 2021*

Primary ODN Total
Barts 155
Birmingham 173
Bristol and Severn 133
Cheshire and Merseyside 101
Eastern Hepatitis Network 134
Greater Manchester and Eastern Cheshire 276
Humberside and North Yorkshire 42
Kent Network via Kings 52
Lancashire and South Cumbria 101
Leicester 80
North Central London 147
North East and Cumbria 166
Nottingham 120
South Thames Hepatitis Network 156
South West Peninsula 59
South Yorkshire 75
Surrey Hepatitis Services 93
Sussex Hepatology Network 97
Thames Valley Hep C ODN 44
Wessex Hep C ODN 117
West London 292
West Yorkshire 144

*Provisional data.

ODNs are based on NHS England Clinical Commissioning Groups (CCGs) geographic boundaries. NHS England allocates a primary or lead ODN for CCGs which may cross more than one ODN.